228 related articles for article (PubMed ID: 18432645)
1. Peptide binding motifs for MHC class I and II molecules.
Biddison WE; Martin R
Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645
[TBL] [Abstract][Full Text] [Related]
2. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
[TBL] [Abstract][Full Text] [Related]
3. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
4. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
[TBL] [Abstract][Full Text] [Related]
5. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
Kashyap M; Jaiswal V; Farooq U
Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
[TBL] [Abstract][Full Text] [Related]
6. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
7. Identification of MHC-Bound Peptides from Dendritic Cells Infected with Salmonella enterica Strain SL1344: Implications for a Nontyphoidal Salmonella Vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Goldberg MF; Jenkins MK; Foster LJ; Brunham RC
J Proteome Res; 2017 Jan; 16(1):298-306. PubMed ID: 27802388
[TBL] [Abstract][Full Text] [Related]
8. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
Nielsen M; Lundegaard C; Lund O
BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
[TBL] [Abstract][Full Text] [Related]
9. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
10. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
Dhiman G; Lohia N; Jain S; Baranwal M
Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
[TBL] [Abstract][Full Text] [Related]
11. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
12. Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism.
Wei X; Wang S; Li Z; Li Z; Qu Z; Wang S; Zou B; Liang R; Xia C; Zhang N
Front Immunol; 2021; 12():592447. PubMed ID: 33717070
[TBL] [Abstract][Full Text] [Related]
13. Defining rules for the peptide-MHC class II interaction.
Sinigaglia F; Hammer J
Curr Opin Immunol; 1994 Feb; 6(1):52-6. PubMed ID: 7513526
[TBL] [Abstract][Full Text] [Related]
14. Peptide binding to MHC class I and II proteins: new avenues from new methods.
Yaneva R; Schneeweiss C; Zacharias M; Springer S
Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
[TBL] [Abstract][Full Text] [Related]
15. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules.
Gaseitsiwe S; Maeurer MJ
Methods Mol Biol; 2009; 524():417-26. PubMed ID: 19377962
[TBL] [Abstract][Full Text] [Related]
16. Peptide binding by class I and class II MHC molecules.
Batalia MA; Collins EJ
Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
[TBL] [Abstract][Full Text] [Related]
17. Structure of peptides associated with class I and class II MHC molecules.
Engelhard VH
Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
[TBL] [Abstract][Full Text] [Related]
18. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
Appella E; Padlan EA; Hunt DF
EXS; 1995; 73():105-19. PubMed ID: 7579970
[TBL] [Abstract][Full Text] [Related]
20. Prediction of MHC class I binding peptides with a new feature encoding technique.
Gök M; Özcerit AT
Cell Immunol; 2012; 275(1-2):1-4. PubMed ID: 22531484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
